Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744C 100 OR 300 mg for the Prevention of Ventricular Arrhythmia-Triggered ICD Interventions

NCT00232297 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00232297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744C 100 OR 300 mg for the Prevention of Ventricular Arrhythmia-Triggered ICD Interventions
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
February 28, 2007
Enrollment
153 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, tachycardia, ventricular, ventricular fibrillation